Literature DB >> 27919909

Severe anemia early in life as a risk factor for sickle-cell kidney disease.

Inmaculada Aban1, Sujatha Baddam2, Lee M Hilliard2, Thomas H Howard2, Daniel I Feig3, Jeffrey D Lebensburger2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27919909      PMCID： PMC5248934          DOI： 10.1182/blood-2016-09-738104

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  Renal transplantation in end-stage sickle cell nephropathy.

Authors:  A O Ojo; T C Govaerts; R L Schmouder; A B Leichtman; S F Leavey; R A Wolfe; P J Held; F K Port; L Y Agodoa
Journal:  Transplantation       Date:  1999-01-27       Impact factor: 4.939

2.  Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease.

Authors:  Lauren J Becton; Ram V Kalpatthi; Elizabeth Rackoff; Deborah Disco; John K Orak; Sherron M Jackson; Ibrahim F Shatat
Journal:  Pediatr Nephrol       Date:  2010-05-27       Impact factor: 3.714

3.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Authors:  Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

4.  Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Authors:  Louise Nielsen; Florence Canouï-Poitrine; Jean-Philippe Jais; Djamal Dahmane; Pablo Bartolucci; Bouteina Bentaarit; Justine Gellen-Dautremer; Philippe Remy; Tomek Kofman; Marie Matignon; Caroline Suberbielle; Christian Jacquelinet; Orianne Wagner-Ballon; Dil Sahali; Philippe Lang; Thibaud Damy; Frédéric Galactéros; Philippe Grimbert; Anoosha Habibi; Vincent Audard
Journal:  Br J Haematol       Date:  2016-03-17       Impact factor: 6.998

5.  Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury.

Authors:  Karl A Nath; Joseph P Grande; Anthony J Croatt; Elena Frank; Noel M Caplice; Robert P Hebbel; Zvonimir S Katusic
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

6.  Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.

Authors:  Anoop Shankar; Liping Sun; Barbara E K Klein; Kristine E Lee; Paul Muntner; F Javier Nieto; Michael Y Tsai; Karen J Cruickshanks; Carla R Schubert; Peter C Brazy; Josef Coresh; Ronald Klein
Journal:  Kidney Int       Date:  2011-08-24       Impact factor: 10.612

7.  Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.

Authors:  Banu Aygun; Nicole A Mortier; Matthew P Smeltzer; Jane S Hankins; Russell E Ware
Journal:  Pediatr Nephrol       Date:  2011-05-11       Impact factor: 3.714

8.  Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia.

Authors:  Sevgi Gurkan; Kyla J Scarponi; Hilary Hotchkiss; Beth Savage; Richard Drachtman
Journal:  Pediatr Nephrol       Date:  2010-06-02       Impact factor: 3.714

9.  Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality.

Authors:  D R Powars; D D Elliott-Mills; L Chan; J Niland; A L Hiti; L M Opas; C Johnson
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

10.  Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Authors:  Pablo Bartolucci; Anoosha Habibi; Thomas Stehlé; Gaetana Di Liberto; Marie Georgine Rakotoson; Justine Gellen-Dautremer; Sylvain Loric; Stéphane Moutereau; Dil Sahali; Orianne Wagner-Ballon; Philippe Remy; Philippe Lang; Philippe Grimbert; Etienne Audureau; Bertrand Godeau; Frédéric Galacteros; Vincent Audard
Journal:  J Am Soc Nephrol       Date:  2015-11-19       Impact factor: 10.121
View more
  10 in total

Review 1.  Fetal Hemoglobin Induction by Epigenetic Drugs.

Authors:  Donald Lavelle; James Douglas Engel; Yogen Saunthararajah
Journal:  Semin Hematol       Date:  2018-04-22       Impact factor: 3.851

2.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

3.  Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.

Authors:  Jeffrey D Lebensburger; Gary R Cutter; Thomas H Howard; Paul Muntner; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2017-04-05       Impact factor: 3.714

4.  Longitudinal study of glomerular hyperfiltration and normalization of estimated glomerular filtration in adults with sickle cell disease.

Authors:  Vimal K Derebail; Qingning Zhou; Emily J Ciccone; Jianwen Cai; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2021-08-16       Impact factor: 8.615

5.  Voxelotor and albuminuria in adults with sickle cell anaemia.

Authors:  Jin Han; Robert E Molokie; Faiz Hussain; Franklin Njoku; Victor R Gordeuk; Santosh L Saraf
Journal:  Br J Haematol       Date:  2022-02-14       Impact factor: 8.615

6.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

Review 7.  Targeting sickle cell disease root-cause pathophysiology with small molecules.

Authors:  Yogen Saunthararajah
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

8.  Investigations of Kidney Dysfunction-Related Gene Variants in Sickle Cell Disease Patients in Cameroon (Sub-Saharan Africa).

Authors:  Valentina J Ngo-Bitoungui; Suzanne Belinga; Khuthala Mnika; Tshepiso Masekoameng; Victoria Nembaware; René G Essomba; Francoise Ngo-Sack; Gordon Awandare; Gaston K Mazandu; Ambroise Wonkam
Journal:  Front Genet       Date:  2021-03-15       Impact factor: 4.599

9.  Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.

Authors:  Robert Molokie; Donald Lavelle; Michel Gowhari; Michael Pacini; Lani Krauz; Johara Hassan; Vinzon Ibanez; Maria A Ruiz; Kwok Peng Ng; Philip Woost; Tomas Radivoyevitch; Daisy Pacelli; Sherry Fada; Matthew Rump; Matthew Hsieh; John F Tisdale; James Jacobberger; Mitch Phelps; James Douglas Engel; Santhosh Saraf; Lewis L Hsu; Victor Gordeuk; Joseph DeSimone; Yogen Saunthararajah
Journal:  PLoS Med       Date:  2017-09-07       Impact factor: 11.069

10.  Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.

Authors:  John D Belcher; Edward Gomperts; Julia Nguyen; Chunsheng Chen; Fuad Abdulla; Zachary M Kiser; David Gallo; Howard Levy; Leo E Otterbein; Gregory M Vercellotti
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.